Friday, February 20, 2009

stage III non–small-cell lung cancer.

a plateau in survival using current chemotherapy agents cisplatin, etoposide and radiation against stage III NSCLC reached.

read more at http://www.hemonctoday.com/article.aspx?rid=33196
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)